Crossmark

Significantly different clinical phenotypes associated with mutations in synthesis and transamidase+remodeling glycosylphosphatidylinositol (GPI)-anchor biosynthesis genes

Crossref DOI link: https://doi.org/10.1186/s13023-020-1313-0

Published Online: 2020-02-04

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Carmody, Leigh C.

Blau, Hannah

Danis, Daniel

Zhang, Xingman A.

Gourdine, Jean-Philippe

Vasilevsky, Nicole

Krawitz, Peter

Thompson, Miles D.

Robinson, Peter N. http://orcid.org/0000-0002-0736-9199
Funding

Funding for this research was provided by:

National Institutes of Health (OD #5R24OD011883)
License Information

Text and Data Mining valid from 2020-02-04

Version of Record valid from 2020-02-04
More Information

Article History

Received: 8 July 2019

Accepted: 21 January 2020

First Online: 4 February 2020

Ethics approval and consent to participate

: Not applicable.

: Not applicable. All data was previously published.

: The authors declare they have no competing interests.

Document is current

Any future updates will be listed below